Occudo Quantitative Strategies LP Liquidia Corp Transaction History

Occudo Quantitative Strategies LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.35 - $16.73 $6,832 - $10,071	602 Added 3.2%	19,422 $286,000
Q4 2023 Feb 14, 2024	SELL	$5.77 - $12.19 $92,804 - $196,063	-16,084 Reduced 46.08%	18,820 $226,000
Q3 2023 Nov 14, 2023	BUY	$6.27 - $8.15 $49,601 - $64,474	7,911 Added 29.31%	34,904 $221,000
Q2 2023 Aug 14, 2023	SELL	$6.63 - $9.9 $57,734 - $86,209	-8,708 Reduced 24.39%	26,993 $211,000
Q1 2023 May 15, 2023	SELL	$5.72 - $7.91 $31,808 - $43,987	-5,561 Reduced 13.48%	35,701 $246,000
Q4 2022 Feb 14, 2023	SELL	$4.68 - $6.54 $53,857 - $75,262	-11,508 Reduced 21.81%	41,262 $262,000
Q3 2022 Nov 14, 2022	BUY	$3.73 - $8.39 $20,071 - $45,146	5,381 Added 11.35%	52,770 $287,000
Q2 2022 Aug 15, 2022	SELL	$3.37 - $7.55 $9,112 - $20,415	-2,704 Reduced 5.4%	47,389 $207,000
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $49,960 - $71,733	9,720 Added 24.08%	50,093 $360,000
Q4 2021 Feb 14, 2022	BUY	$2.71 - $5.17 $38,614 - $73,667	14,249 Added 54.54%	40,373 $197,000
Q3 2021 Nov 15, 2021	SELL	$2.28 - $2.95 $3,921 - $5,074	-1,720 Reduced 6.18%	26,124 $72,000
Q2 2021 Aug 16, 2021	BUY	$2.51 - $3.11 $69,888 - $86,594	27,844 New	27,844 $80,000

162

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.